Prenetics Global Limited (NASDAQ:PRENW) Short Interest Update

Prenetics Global Limited (NASDAQ:PRENW) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 43,726 shares, an increase of 198.8% from the February 26th total of 14,634 shares. Based on an average trading volume of 37,005 shares, the short-interest ratio is currently 1.2 days.

Prenetics Global Trading Down 10.0%

PRENW stock traded down $0.00 on Thursday, reaching $0.02. 25,000 shares of the company were exchanged, compared to its average volume of 20,961. Prenetics Global has a 12 month low of $0.01 and a 12 month high of $0.07. The stock’s fifty day moving average price is $0.02 and its 200 day moving average price is $0.02.

About Prenetics Global

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.